
Loading, please wait...

Loading, please wait...

Growing evidence suggests that immune dysregulation significantly contributes to the pathophysiology of neurodevelopmental disorders. Specifically, research into the profile of Cytokines in ADHD has identified distinct signatures that distinguish affected adolescents from healthy peers. A recent cross-sectional study analyzed adolescents aged 12 to 18 to explore the balance of T-helper cell subsets and microglial regulatory markers. Furthermore, the findings highlight a shift toward systemic inflammation in those diagnosed with the condition.
The study found that serum levels of several key markers, including IL-12, IL-17, IL-23, IL-4, and IL-10, were significantly higher in the ADHD group. Among these, IL-12 and IL-17 demonstrated the highest diagnostic yield with an AUC of 0.77. Additionally, IL-12 remained a strong independent predictor during multivariate analysis. These results indicate a proinflammatory activation dominated by Th1 and Th17 pathways. However, the elevation of IL-4 and IL-10 suggests a partially compensatory Th2 and Treg response aimed at modulating this inflammation.
Beyond T-cell activity, the study investigated microglia regulatory cytokines like IL-34 and CSF-1. While CSF-1 levels remained stable across groups, IL-34 showed an increase that nearly reached statistical significance. This suggests potential microglial divergence in ADHD pathophysiology. Consequently, these findings underscore the need for multidimensional immunophenotyping in clinical practice. Developing immune-targeted therapeutic strategies could offer a novel approach to managing symptoms in adolescents who do not respond to conventional treatments.
Research has identified significant increases in proinflammatory cytokines such as IL-12, IL-17, and IL-23, alongside compensatory increases in anti-inflammatory markers like IL-4 and IL-10.
Currently, markers like IL-12 and IL-17 show a moderate diagnostic yield (AUC of approximately 0.77). While they are strong predictors, they are not yet used as standalone diagnostic tools in routine clinical practice.
Th1 and Th17 dominance indicates a state of chronic proinflammatory activation, which may impact neural development and neurotransmitter pathways associated with attention and executive function.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that IL-12 and IL-17 levels are significantly elevated in adolescents with ADHD, pointing to a Th1/Th17-dominated immune profile....
5 months ago

A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today

Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today